[go: up one dir, main page]

GB202315863D0 - Formulations - Google Patents

Formulations

Info

Publication number
GB202315863D0
GB202315863D0 GBGB2315863.7A GB202315863A GB202315863D0 GB 202315863 D0 GB202315863 D0 GB 202315863D0 GB 202315863 A GB202315863 A GB 202315863A GB 202315863 D0 GB202315863 D0 GB 202315863D0
Authority
GB
United Kingdom
Prior art keywords
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2315863.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mosanna Therapeutics Ag
Original Assignee
Mosanna Therapeutics Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mosanna Therapeutics Ag filed Critical Mosanna Therapeutics Ag
Priority to GBGB2315863.7A priority Critical patent/GB202315863D0/en
Publication of GB202315863D0 publication Critical patent/GB202315863D0/en
Priority to PCT/EP2024/077436 priority patent/WO2025068591A1/en
Priority to TW113137345A priority patent/TW202529757A/en
Ceased legal-status Critical Current

Links

GBGB2315863.7A 2023-09-28 2023-10-17 Formulations Ceased GB202315863D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB2315863.7A GB202315863D0 (en) 2023-10-17 2023-10-17 Formulations
PCT/EP2024/077436 WO2025068591A1 (en) 2023-09-28 2024-09-30 Intranasal formulations for treating obstructive sleep apnea
TW113137345A TW202529757A (en) 2023-09-28 2024-09-30 Intranasal formulations for treating obstructive sleep apnea

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2315863.7A GB202315863D0 (en) 2023-10-17 2023-10-17 Formulations

Publications (1)

Publication Number Publication Date
GB202315863D0 true GB202315863D0 (en) 2023-11-29

Family

ID=88863810

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2315863.7A Ceased GB202315863D0 (en) 2023-09-28 2023-10-17 Formulations

Country Status (1)

Country Link
GB (1) GB202315863D0 (en)

Similar Documents

Publication Publication Date Title
GB202117828D0 (en) New formulations
IL290356A (en) Larazotide formulations
GB201904338D0 (en) Fluorouracil-containing formulations
IL284691A (en) Formulations
GB202204171D0 (en) Novel formulations
IL319149A (en) Upadacitinib formulation
GB202018889D0 (en) Formulations
GB202009684D0 (en) Formulations
GB202009685D0 (en) Formulations
IL321617A (en) Bezuclastinib formulations
GB202315863D0 (en) Formulations
GB202307059D0 (en) Formulations
GB202216961D0 (en) 5-meo-mt formulations
GB202115127D0 (en) Formulations
GB202115121D0 (en) Formulations
GB202103762D0 (en) Formulations
GB202103780D0 (en) Formulations
GB202103785D0 (en) Formulations
GB202018250D0 (en) Formulations
GB202018251D0 (en) Formulations
GB202108259D0 (en) Novel formulations
GB202004814D0 (en) Novel formulations
GB202004811D0 (en) Novel Formulations
GB202417829D0 (en) Formulations
IL323027A (en) Formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)